看來載入頁面時發生了錯誤.
我們的團隊已收到通知,但若此問題持續,請透過電郵支援widget工具聯絡我們。
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | No | No |
Is net profit margin increasing? | Yes | Yes |
Is asset turnover increasing? | No | No |
Is equity multiplier increasing? | Yes | No |
Competitors Used |
---|
Narmada Gelatines Limited |
Privi Speciality Chemicals Limited |
Bharat Rasayan Limited |
C.J. Gelatine Products Limited |
3B Blackbio Dx Limited |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
526,739 | 530,117 | 590,021 | 507,515 | 532,067 | 540,904 | |||
Return On Equity | ||||||||
Latest Twelve Months | NA | NA | NA | NA | NA | NA | ||
Fiscal Year - 1 | 13% | 3% | 15% | 3% | 15% | 7% | ||
Fiscal Year - 2 | 9% | 13% | 24% | 5% | 23% | 7% | ||
Fiscal Year - 3 | 6% | 18% | 25% | 4% | 139% | 4% | ||
Fiscal Year - 4 | 10% | 25% | 32% | 3% | 28% | 10% | ||
Fiscal Year - 5 | 8% | 18% | 32% | 4% | 26% | 12% | ||
Average | 9% | 15% | 26% | 4% | 46% | 8% | ||
Median | 9% | 18% | 25% | 4% | 26% | 7% | ||
Benchmarks | Ticker | |||||||
Narmada Gelatines Limited | BSE:526739 | |||||||
Privi Speciality Chemicals Limited | BSE:530117 | |||||||
Bharat Rasayan Limited | BSE:590021 | |||||||
C.J. Gelatine Products Limited | BSE:507515 | |||||||
3B Blackbio Dx Limited | BSE:532067 |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | Feb-42 | May-51 | Jun-15 | Jul-89 | Sep-56 | Dec-80 | ||
Latest Fiscal Year | Mar-24 | Mar-24 | Mar-24 | Mar-24 | Mar-24 | Mar-24 | ||
LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
Revenues | ||||||||
Latest Twelve Months | 1,886 | 19,720 | 11,761 | 412 | 971 | 1,057 | ||
Fiscal Year | 1,818 | 17,522 | 10,446 | 409 | 742 | 1,040 | ||
Fiscal Year - 1 | 1,911 | 16,078 | 12,343 | 368 | 621 | 1,016 | ||
Fiscal Year - 2 | 1,574 | 14,037 | 13,012 | 397 | 875 | 1,027 | ||
Fiscal Year - 3 | 1,349 | 12,766 | 10,920 | 390 | 2,296 | 736 | ||
Fiscal Year - 4 | 1,343 | 13,241 | 12,151 | 283 | 305 | 799 | ||
Fiscal Year - 5 | 1,258 | 13,410 | 9,922 | 258 | 240 | 1,032 | ||
Net Income | ||||||||
Latest Twelve Months | 171 | 1,515 | 1,829 | (2) | 475 | 20 | ||
Fiscal Year | 153 | 949 | 955 | (19) | 321 | 21 | ||
Fiscal Year - 1 | 153 | 222 | 1,246 | 2 | 259 | 19 | ||
Fiscal Year - 2 | 123 | 974 | 1,760 | 3 | 322 | 18 | ||
Fiscal Year - 3 | 85 | 1,169 | 1,639 | 3 | 1,139 | 11 | ||
Fiscal Year - 4 | 129 | 1,460 | 1,576 | 2 | 77 | 24 | ||
Fiscal Year - 5 | 101 | 942 | 1,115 | 4 | 52 | 26 | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | NA | NA | NA | NA | NA | NA | ||
Latest Fiscal Quarter | NA | NA | NA | NA | NA | NA | ||
Fiscal Year | 1,336 | 23,425 | 11,974 | 331 | 2,481 | 853 | ||
Fiscal Year - 1 | 1,166 | 23,911 | 10,736 | 355 | 2,141 | 873 | ||
Fiscal Year - 2 | 1,699 | 21,760 | 10,856 | 348 | 1,921 | 909 | ||
Fiscal Year - 3 | 1,649 | 15,402 | 9,079 | 326 | 1,935 | 950 | ||
Fiscal Year - 4 | 1,608 | 13,837 | 7,519 | 310 | 448 | 855 | ||
Fiscal Year - 5 | 1,546 | 14,257 | 7,557 | 309 | 363 | 764 | ||
Fiscal Year - 6 | 1,401 | 10,529 | 5,037 | 321 | 304 | 696 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 1,009 | 8,643 | 9,059 | 58 | 2,084 | 296 | ||
Latest Fiscal Quarter | 1,107 | 9,924 | 10,641 | 43 | 2,466 | 313 | ||
Fiscal Year | 1,089 | 9,244 | 9,879 | 47 | 2,230 | 308 | ||
Fiscal Year - 1 | 939 | 8,291 | 8,933 | 72 | 1,933 | 291 | ||
Fiscal Year - 2 | 1,452 | 8,123 | 7,700 | 76 | 1,530 | 276 | ||
Fiscal Year - 3 | 1,388 | 7,225 | 7,273 | 78 | 1,321 | 258 | ||
Fiscal Year - 4 | 1,364 | 6,121 | 5,641 | 85 | 321 | 247 | ||
Fiscal Year - 5 | 1,308 | 5,757 | 4,088 | 88 | 225 | 231 | ||
Fiscal Year - 6 | 1,238 | 4,869 | 2,982 | 90 | 184 | 215 |